Omada Health, Inc.
OMDA
$18.73
$0.532.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.85% | 11.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.85% | 11.66% | |||
| Cost of Revenue | 8.99% | -8.66% | |||
| Gross Profit | 11.82% | 26.35% | |||
| SG&A Expenses | 7.67% | 9.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.35% | 3.72% | |||
| Operating Income | 42.15% | 48.26% | |||
| Income Before Tax | 40.16% | 43.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 40.16% | 43.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.16% | 43.79% | |||
| EBIT | 42.15% | 48.26% | |||
| EBITDA | 61.43% | 57.64% | |||
| EPS Basic | 77.20% | 78.92% | |||
| Normalized Basic EPS | 92.32% | 78.91% | |||
| EPS Diluted | 77.20% | 78.92% | |||
| Normalized Diluted EPS | 92.32% | 78.91% | |||
| Average Basic Shares Outstanding | 162.43% | 166.61% | |||
| Average Diluted Shares Outstanding | 162.43% | 166.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||